Al-Shibli A, Konrad M, Altay W, Al Masri O, Al-Gazali L, Al Attrach I. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC): report of three cases with a novel mutation in CLDN19 gene. Saudi J Kidney Dis Transpl 2013; 24:
338-344
Alvarez-Hernandez D, Santamaria I, Rodriguez-Garcia M, Iglesias P, Delgado-Lillo R, Cannata-Andia JB. A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms. J Mol Endocrinol 2003; 31: 255-262
Arthur JM, Lawrence MS, Payne CR, Rane MJ, McLeish KR. The calcium-sensing receptor stimulates JNK in MDCK cells. Biochem Biophys Res Commun 2000; 275: 538-541
Bai M, Janicic N, Trivedi S, Quinn SJ, Cole DE, Brown EM, Hendy GN. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest 1997a; 99: 1917-1925
Bai M, Pearce SH, Kifor O, Trivedi S, Stauffer UG, Thakker RV, Brown EM, Steinmann B. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 1997b; 99: 88-96
Bai M, Quinn S, Trivedi S, Kifor O, Pearce SH, Pollak MR, Krapcho K, Hebert SC, Brown EM. Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem 1996; 271: 19537-19545
Bai M, Trivedi S, Brown EM. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 1998; 273:
23605-23610
Barakat AJ, Rennert OM. Gitelman's syndrome (familial hypokalemia-hypomagnesemia). J Nephrol 2001; 14: 43-47
Baron J, Winer KK, Yanovski JA, Cunningham AW, Laue L, Zimmerman D, Cutler GB, Jr. Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996; 5: 601-606
Baumber L, Tufarelli C, Patel S, King P, Johnson CA, Maher ER, Trembath RC.
Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism. J Med Genet 2005; 42: 443-448
Bilezikian JP, Khan AA, Potts JT, Jr., Third International Workshop on the Management of Asymptomatic Primary H. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009; 94: 335-339
Blair JW, Carachi R. Neonatal primary hyperparathyroidism--a case report and review of the literature. Eur J Pediatr Surg 1991; 1: 110-114
Brandi ML. Genetics of hypoparathyroidism and pseudohypoparathyroidism. J Endocrinol Invest 2011; 34: 27-34
Brauner-Osborne H, Jensen AA, Sheppard PO, O'Hara P, Krogsgaard-Larsen P. The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem 1999; 274: 18382-18386
Breitwieser GE. Minireview: the intimate link between calcium sensing receptor trafficking and signaling: implications for disorders of calcium homeostasis. Mol Endocrinol 2012; 26: 1482-1495
Breitwieser GE. The calcium sensing receptor life cycle: trafficking, cell surface expression, and degradation. Best Pract Res Clin Endocrinol Metab 2013a; 27: 303-313 Breitwieser GE. Pharmacoperones and the calcium sensing receptor: Exogenous and endogenous regulators. Pharmacological research : the official journal of the Italian Pharmacological Society 2013b:
Brennan SC, Conigrave AD. Regulation of cellular signal transduction pathways by the extracellular calcium-sensing receptor. Curr Pharm Biotechnol 2009; 10: 270-281
Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate.
Kidney Int 1999a; 55: 1284-1292
Brown AJ, Sanders EJ. Interactions between mesoderm cells and the extracellular matrix following gastrulation in the chick embryo. J Cell Sci 1991; 99 ( Pt 2): 431-441 Brown EM. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev 1991; 71: 371-411
Brown EM. Mutations in the calcium-sensing receptor and their clinical implications.
Horm Res 1997; 48: 199-208
Brown EM. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 1999; 106: 238-253
Brown EM. The extracellular Ca2+-sensing receptor: central mediator of systemic calcium homeostasis. Annu Rev Nutr 2000; 20: 507-533
Brown EM. The calcium-sensing receptor (CaR) and its disorders. Hormones (Athens) 2002; 1: 10-21
Brown EM. Calcium sensing by endocrine cells. Endocr Pathol 2004; 15: 187-219
Brown EM. The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics. Subcell Biochem 2007a; 45: 139-167
Brown EM. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metab 2007b; 3: 122-133
Brown EM, Chattopadhyay N, Vassilev PM, Hebert SC. The calcium-sensing receptor (CaR) permits Ca2+ to function as a versatile extracellular first messenger. Recent Prog Horm Res 1998a; 53: 257-280; discussion 280-251
Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580
Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-297
Brown EM, Pollak M, Hebert SC. The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med 1998b; 49: 15-29
Brown EM, Pollak M, Riccardi D, Hebert SC. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from parathyroid and kidney: new insights into the physiology and pathophysiology of calcium metabolism. Nephrol Dial Transplant 1994a;
9: 1703-1706
Brown EM, Vassilev PM, Quinn S, Hebert SC. G-protein-coupled, extracellular Ca(2+)-sensing receptor: a versatile regulator of diverse cellular functions. Vitam Horm 1999b;
55: 1-71
Brown PM, Debanne MT, Grothe S, Bergsma D, Caron M, Kay C, O'Connor-McCourt MD. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
Eur J Biochem 1994b; 225: 223-233
Cavanaugh A, McKenna J, Stepanchick A, Breitwieser GE. Calcium-sensing receptor biosynthesis includes a cotranslational conformational checkpoint and endoplasmic reticulum retention. J Biol Chem 285: 19854-19864
Cetani F, Pardi E, Borsari S, Tonacchera M, Morabito E, Pinchera A, Marcocci C, Dipollina G. Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation. Clin Endocrinol (Oxf) 2003; 58: 199-206
Cha SK, Huang C, Ding Y, Qi X, Huang CL, Miller RT. Calcium-sensing receptor decreases cell surface expression of the inwardly-rectifying K channel Kir4.1. J Biol Chem:
Chakravarti B, Chattopadhyay N, Brown EM. Signaling through the extracellular calcium-sensing receptor (CaSR). Advances in experimental medicine and biology 2012; 740:
103-142
Chattopadhyay N. Biochemistry, physiology and pathophysiology of the extracellular calcium-sensing receptor. Int J Biochem Cell Biol 2000; 32: 789-804
Chattopadhyay N. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. Am J Physiol Endocrinol Metab 2006; 290: E761-770
Chattopadhyay N, Baum M, Bai M, Riccardi D, Hebert SC, Harris HW, Brown EM.
Ontogeny of the extracellular calcium-sensing receptor in rat kidney. Am J Physiol 1996;
271: F736-743
Chattopadhyay N, Brown EM. Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 2006; 89: 189-202
Cole DE, Janicic N, Salisbury SR, Hendy GN. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 1997; 71: 202-210
Colussi G, Rombola G, De Ferrari ME. Distal nephron function in familial hypokalemia-hypomagnesemia (Gitelman's syndrome). Nephron 1994; 66: 122-123
Conigrave AD, Ward DT. Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways. Best Pract Res Clin Endocrinol Metab 2013; 27: 315-331
Cusano NE, Bilezikian JP. Comparative effectiveness of combination osteoanabolic and antiresorptive therapy for osteoporosis: an update. Journal of comparative effectiveness research 2013; 2: 511-513
Cusano NE, Rubin MR, Irani D, Sliney J, Jr., Bilezikian JP. Use of parathyroid hormone in hypoparathyroidism. J Endocrinol Invest 2013a; 36: 1121-1127
Cusano NE, Rubin MR, McMahon DJ, Irani D, Tulley A, Sliney J, Jr., Bilezikian JP. The effect of PTH(1-84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab 2013b; 98: 2356-2361
Cusano NE, Rubin MR, McMahon DJ, Zhang C, Ives R, Tulley A, Sliney J, Jr., Cremers SC, Bilezikian JP. Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety. J Clin Endocrinol Metab 2013c; 98: 137-144 Cusano NE, Rubin MR, Sliney J, Jr., Bilezikian JP. Mini-review: new therapeutic options in hypoparathyroidism. Endocrine 2012; 41: 410-414
Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2013d; 16: 33-39
D'Souza-Li L. The calcium-sensing receptor and related diseases. Arq Bras Endocrinol Metabol 2006; 50: 628-639
D'Souza-Li L, Canaff L, Janicic N, Cole DE, Hendy GN. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Hum Mutat 2001; 18: 411-421
D'Souza-Li L, Yang B, Canaff L, Bai M, Hanley DA, Bastepe M, Salisbury SR, Brown EM, Cole DE, Hendy GN. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002; 87: 1309-1318
Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268: 14553-14556
De Sanctis V, Soliman A, Fiscina B. Hypoparathyroidism: from diagnosis to treatment.
Current opinion in endocrinology, diabetes, and obesity 2012; 19: 435-442
Diaz-Soto G, Mora-Porta M, Nicolau J, Perea V, Halperin I, Puig-Domingo M. Efficacy and safety of long term treatment of unresponsive hypoparathyroidism using multipulse subcutaneous infusion of teriparatide. Horm Metab Res 2012; 44: 708-710
Doumith R, Ulmann A, Biclet P, Rieu M, Dubost C. [An unrecognised cause of hypercalcaemia: hypercalcaemia-hyocalcluria syndrome]. Nouv Presse Med 1980; 9:
1157-1159
Egbuna OI, Brown EM. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 2008; 22: 129-148
Fajtova VT, Quinn SJ, Brown EM. Cytosolic calcium responses of single rMTC 44-2 cells to stimulation with external calcium and potassium. Am J Physiol 1991; 261: E151-158 Felderbauer P, Hoffmann P, Einwachter H, Bulut K, Ansorge N, Schmitz F, Schmidt WE.
A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol 2003;
3: 34
Finegold DN, Armitage MM, Galiani M, Matise TC, Pandian MR, Perry YM, Deka R, Ferrell RE. Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13. Pediatr Res 1994; 36: 414-417
Galitzer H, Lavi-Moshayoff V, Nechama M, Meir T, Silver J, Naveh-Many T. The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells. BMC Biol 2009; 7: 17
Gamba G, Friedman PA. Thick ascending limb: the Na(+):K (+):2Cl (-) co-transporter, NKCC2, and the calcium-sensing receptor, CaSR. Pflugers Arch 2009; 458: 61-76
Garcia Soblechero E, Ferrer Castillo MT, Jimenez Crespo B, Dominguez Quintero ML, Gonzalez Fuentes C. Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet. Neonatology 2013; 104: 104-108
Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF, Fuller F. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995; 270: 12919-12925
Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966; 79: 221-235 Gjata M, Tase M, Gjata A, Gjergji Z. Gitelman's syndrome (familial hypokalemia-hypomagnesemia). Hippokratia 2007; 11: 150-153
Goldsmith PK, Fan GF, Ray K, Shiloach J, McPhie P, Rogers KV, Spiegel AM.
Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor. J Biol Chem 1999; 274: 11303-11309
Grant MP, Stepanchick A, Breitwieser GE. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor. Mol Endocrinol 2012; 26: 2081-2091
Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450
Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 1998; 273:
1839-1842
Hammerland LG, Krapcho KJ, Garrett JE, Alasti N, Hung BC, Simin RT, Levinthal C, Nemeth EF, Fuller FH. Domains determining ligand specificity for Ca2+ receptors. Mol Pharmacol 1999; 55: 642-648
Hammond CM, White D, Tomic J, Shi Y, Spaner DE. Extracellular calcium sensing promotes human B-cell activation and function. Blood 2007; 110: 3985-3995
Hampson G, Konrad MA, Scoble J. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene. BMC Nephrol 2008; 9: 12
Hannan FM, Nesbit MA, Zhang C, Cranston T, Curley AJ, Harding B, Fratter C, Rust N, Christie PT, Turner JJ, Lemos MC, Bowl MR, Bouillon R, Brain C, Bridges N, Burren C, Connell JM, Jung H, Marks E, McCredie D, Mughal Z, Rodda C, Tollefsen S, Brown EM, Yang JJ, Thakker RV. Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. Hum Mol Genet 2012; 21: 2768-2778
Hannan FM, Thakker RV. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best Pract Res Clin Endocrinol Metab 27:
359-371
Hauache OM. Extracellular calcium-sensing receptor: structural and functional features and association with diseases. Braz J Med Biol Res 2001; 34: 577-584
Heaney RP. Lead in calcium supplements. JAMA 2000a; 284: 3126
Heaney RP. Vitamin D: how much do we need, and how much is too much? Osteoporos Int 2000b; 11: 553-555
Heaney RP, Berner B, Louie-Helm J. Dosing regimen for calcium supplementation. J Bone Miner Res 2000a; 15: 2291
Heaney RP, Dowell MS, Rafferty K, Bierman J. Bioavailability of the calcium in fortified soy imitation milk, with some observations on method. Am J Clin Nutr 2000b; 71: 1166-1169
Heath DA. Clinical manifestations of abnormalities of the calcium sensing receptor. Clin Endocrinol (Oxf) 1998; 48: 257-258
Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2000; 16: 281-296
Hendy GN, Guarnieri V, Canaff L. Chapter 3 calcium-sensing receptor and associated diseases. Prog Mol Biol Transl Sci 2009; 89: 31-95
Hendy GN, Minutti C, Canaff L, Pidasheva S, Yang B, Nouhi Z, Zimmerman D, Wei C, Cole DE. Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene. J Clin Endocrinol Metab 2003; 88: 3674-3681
Hinnie J, Bell E, McKillop E, Gallacher S. The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int 2001; 68: 216-218
Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, Seidman CE. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 1995; 11: 389-394
Hofer AM, Brown EM. Extracellular calcium sensing and signalling. Nature reviews.
Molecular cell biology 2003; 4: 530-538
Hofer AM, Curci S, Doble MA, Brown EM, Soybel DI. Intercellular communication mediated by the extracellular calcium-sensing receptor. Nat Cell Biol 2000; 2: 392-398 Holick MF. Vitamin D and bone health. J Nutr 1996; 126: 1159S-1164S
Holick MF, Chen ML, Kong XF, Sanan DK. Clinical uses for calciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective. J Investig Dermatol Symp Proc 1996; 1: 1-9
Hu J. Allosteric modulators of the human calcium-sensing receptor: structures, sites of action, and therapeutic potentials. Endocr Metab Immune Disord Drug Targets 2008; 8:
192-197
Hu J, Mora S, Colussi G, Proverbio MC, Jones KA, Bolzoni L, De Ferrari ME, Civati G, Spiegel AM. Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain. J Bone Miner Res 2002;
17: 1461-1469
Hu J, Mora S, Weber G, Zamproni I, Proverbio MC, Spiegel AM. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor. J Bone Miner Res 2004; 19: 578-586 Hu J, Spiegel AM. Structure and function of the human calcium-sensing receptor:
insights from natural and engineered mutations and allosteric modulators. J Cell Mol Med 2007; 11: 908-922
Huang C, Miller RT. The calcium-sensing receptor and its interacting proteins. J Cell Mol Med 2007a; 11: 923-934
Huang C, Miller RT. Regulation of renal ion transport by the calcium-sensing receptor:
an update. Curr Opin Nephrol Hypertens 2007b; 16: 437-443
Huang Y, Breitwieser GE. Rescue of calcium-sensing receptor mutants by allosteric modulators reveals a conformational checkpoint in receptor biogenesis. J Biol Chem 2007; 282: 9517-9525
Huang Y, Niwa J, Sobue G, Breitwieser GE. Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin. J Biol Chem 2006; 281: 11610-11617
Huang Y, Zhou Y, Castiblanco A, Yang W, Brown EM, Yang JJ. Multiple Ca(2+)-binding sites in the extracellular domain of the Ca(2+)-sensing receptor corresponding to cooperative Ca(2+) response. Biochemistry 2009; 48: 388-398
Janicic N, Soliman E, Pausova Z, Seldin MF, Riviere M, Szpirer J, Szpirer C, Hendy GN.
Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm Genome 1995; 6: 798-801
Janner M, Mullis PE. [Impaired calcium homeostasis, clinical impact]. Ther Umsch 2007;
64: 271-275
Jensen AA, Brauner-Osborne H. Allosteric modulation of the calcium-sensing receptor.
Curr Neuropharmacol 2007; 5: 180-186
Jensen AA, Hansen JL, Sheikh SP, Brauner-Osborne H. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). Eur J Biochem 2002; 269: 5076-5087
Jensen AA, Spalding TA, Burstein ES, Sheppard PO, O'Hara PJ, Brann MR, Krogsgaard-Larsen P, Brauner-Osborne H. Functional importance of the Ala(116)-Pro(136) region in the calcium-sensing receptor. Constitutive activity and inverse agonism in a family C G-protein-coupled receptor. J Biol Chem 2000; 275: 29547-29555 Jiang Y, Minet E, Zhang Z, Silver PA, Bai M. Modulation of interprotomer relationships is important for activation of dimeric calcium-sensing receptor. J Biol Chem 2004; 279:
14147-14156
Khan AA, Bilezikian JP, Potts JT, Jr., Guest Editors for the Third International Workshop on Asymptomatic Primary H. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab 2009; 94: 333-334
Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, Yao T, Kifor I, Brown EM.
Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 2001; 280: F291-302
Kinoshita Y, Hori M, Taguchi M, Watanabe S, Fukumoto S. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2014; 99: E363-368
Kobayashi M, Tanaka H, Tsuzuki K, Tsuyuki M, Igaki H, Ichinose Y, Aya K, Nishioka N, Seino Y. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 2716-2719 Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A, Ruf R, Deschenes G, Antignac C, Guay-Woodford L, Knoers NV, Seyberth HW, Feldmann D, Hildebrandt F. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000; 11: 1449-1459
Kruse K. [Hypoparathyroidism and pseudohypoparathyroidism. New aspects of the pathogenesis, diagnosis and therapy]. Monatsschr Kinderheilkd 1988; 136: 652-666 Kuwertz-Broking E, Frund S, Bulla M, Kleta R, August C, Kisters K. Familial hypomagnesemia-hypercalciuria in 2 siblings. Clin Nephrol 2001; 56: 155-161
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
Laemmli UK, Beguin F, Gujer-Kellenberger G. A factor preventing the major head protein of bacteriophage T4 from random aggregation. Journal of molecular biology 1970a; 47: 69-85
Laemmli UK, Molbert E, Showe M, Kellenberger E. Form-determining function of the genes required for the assembly of the head of bacteriophage T4. Journal of molecular biology 1970b; 49: 99-113
Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nature reviews. Cancer 2003; 3: 601-614
Law WM, Jr., Heath H, 3rd. Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med 1985;
102: 511-519
Lazarus S, Pretorius CJ, Khafagi F, Campion KL, Brennan SC, Conigrave AD, Brown EM, Ward DT. A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia. Eur J Endocrinol:
Leach K, Sexton PM, Christopoulos A, Conigrave AD. Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders. British journal of pharmacology 2013:
Letz S, Rus R, Haag C, Dorr HG, Schnabel D, Mohlig M, Schulze E, Frank-Raue K, Raue F, Mayr B, Schofl C. Novel activating mutations of the calcium-sensing receptor:
the calcilytic NPS-2143 mitigates excessive signal transduction of mutant receptors. J Clin Endocrinol Metab 95: E229-233
Lienhardt A, Bai M, Lagarde JP, Rigaud M, Zhang Z, Jiang Y, Kottler ML, Brown EM, Garabedian M. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 2001; 86: 5313-5323
Lienhardt A, Garabedian M, Bai M, Sinding C, Zhang Z, Lagarde JP, Boulesteix J, Rigaud M, Brown EM, Kottler ML. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2000; 85: 1695-1702
Lietman SA, Tenenbaum-Rakover Y, Jap TS, Yi-Chi W, De-Ming Y, Ding C, Kussiny N, Levine MA. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab 2009; 94: 4372-4379
Linglart A, Rothenbuhler A, Gueorgieva I, Lucchini P, Silve C, Bougneres P. Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism. J Clin Endocrinol Metab 2011; 96: 3308-3312
Loris Pablo C, Martin de Vicente C, Abio Albero S, Justa Roldan M, Ferrer Novella C.
[Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Association with ocular abnormalities]. An Pediatr (Barc) 2004; 61: 502-508
Maeda SS, Fortes EM, Oliveira UM, Borba VC, Lazaretti-Castro M. Hypoparathyroidism and pseudohypoparathyroidism. Arq Bras Endocrinol Metabol 2006; 50: 664-673
Magno AL, Ward BK, Ratajczak T. The Calcium-Sensing Receptor: A Molecular Perspective. Endocr Rev:
Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW, Jr., Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 1981a; 60: 397-412
Marx SJ, Attie MF, Stock JL, Spiegel AM, Levine MA. Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
J Clin Endocrinol Metab 1981b; 52: 736-740
McNeil L, Hobson S, Nipper V, Rodland KD. Functional calcium-sensing receptor expression in ovarian surface epithelial cells. Am J Obstet Gynecol 1998a; 178: 305-313 McNeil SE, Hobson SA, Nipper V, Rodland KD. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 1998b; 273: 1114-1120
Michelis MF, Drash AL, Linarelli LG, De Rubertis FR, Davis BB. Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis.
(Evaluation of the pathophysiological role of parathyroid hormone). Metabolism 1972;
21: 905-920
Michels TC, Kelly KM. Parathyroid disorders. American family physician 2013; 88: 249-257
Mittelman SD, Hendy GN, Fefferman RA, Canaff L, Mosesova I, Cole DE, Burkett L, Geffner ME. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone. J Clin Endocrinol Metab 2006; 91: 2474-2479
Miyashiro K, Kunii I, Manna TD, de Menezes Filho HC, Damiani D, Setian N, Hauache OM. Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor. J Clin Endocrinol Metab 2004; 89: 5936-5941 Moller AP, Merino S, Brown CR, Robertson RJ. Immune defense and host sociality: a comparative study of swallows and martins. Am Nat 2001; 158: 136-145
Mun HC, Franks AH, Culverston EL, Krapcho K, Nemeth EF, Conigrave AD. The Venus Fly Trap domain of the extracellular Ca2+ -sensing receptor is required for L-amino acid sensing. J Biol Chem 2004; 279: 51739-51744
Nagase T, Murakami T, Tsukada T, Kitamura R, Chikatsu N, Takeo H, Takata N, Yasuda H, Fukumoto S, Tanaka Y, Nagata N, Yamaguchi K, Akatsu T, Yamamoto M. A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor. J Clin Endocrinol Metab 2002; 87: 2681-2687
Nakajima K, Yamazaki K, Kimura H, Takano K, Miyoshi H, Sato K. Novel gain of function mutations of the calcium-sensing receptor in two patients with PTH-deficient hypocalcemia. Intern Med 2009; 48: 1951-1956
Nanjo K, Nagai S, Shimizu C, Tajima T, Kondo T, Miyoshi H, Yoshioka N, Koike T.
Identification and functional analysis of novel calcium-sensing receptor gene mutation in familial hypocalciuric hypercalcemia. Endocr J 57: 787-792
Nemeth EF, Scarpa A. Are changes in intracellular free calcium necessary for regulating secretion in parathyroid cells? Ann N Y Acad Sci 1987; 493: 542-551
Okazaki R, Chikatsu N, Nakatsu M, Takeuchi Y, Ajima M, Miki J, Fujita T, Arai M, Totsuka Y, Tanaka K, Fukumoto S. A novel activating mutation in calcium-sensing